Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.

Nicolaos Christodoulides, Floriano N. Pierre, Ximena Sanchez, Luanyi Li, Kyle Hocquard, Aaron Patton, Rachna Muldoon, Craig S. Miller, Jeffrey L. Ebersole, Spencer W Redding, Chih Ko Yeh, Wieslaw Furmaga, David A. Wampler, Biykem Bozkurt, Christie M. Ballantyne, John T. McDevitt

Producción científica: Review articlerevisión exhaustiva

37 Citas (Scopus)


Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is an ever-increasing need and demand for novel and more efficient diagnostic tools for the early detection of cardiovascular disease, especially at the point-of-care (POC). This article reviews the programmable bio-nanochip (P-BNC) system, a new medical microdevice approach with the capacity to deliver both high performance and reduced cost. This fully integrated, total analysis system leverages microelectronic components, microfabrication techniques, and nanotechnology to noninvasively measure multiple cardiac biomarkers in complex fluids, such as saliva, while offering diagnostic accuracy equal to laboratory-confined reference methods. This article profiles the P-BNC approach, describes its performance in real-world testing of clinical samples, and summarizes new opportunities for medical microdevices in the field of cardiac diagnostics.

Idioma originalEnglish (US)
Páginas (desde-hasta)6-12
Número de páginas7
PublicaciónMethodist DeBakey cardiovascular journal
EstadoPublished - ene 2012

ASJC Scopus subject areas

  • General Medicine


Profundice en los temas de investigación de 'Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.'. En conjunto forman una huella única.

Citar esto